Prevalence of Substance Use in Patients With Cancer Receiving Radiation Therapy

Amanda Choflet, DNP, RN, OCN®; Amol K. Narang, MD; Laura Herald Hoofring, MSN, RN; Sarah Bonerigo, MPAS, PA-C; Omar Y. Mian, MD, PhD; Lisa Katulis, BA, BSN, MHA, MBA; Zhi Cheng, MD, MPH; and Susan Appling, PhD, CRNP
CJON
10.1188/16.CJON.397-402

Description

Background: Individuals with cancer and risky alcohol and illicit substance use (AISU) are more likely to suffer diminished quality of life and subpar treatment outcomes. The prevalence of AISU in patients with cancer is poorly understood.

Objectives: This article reports on the results of a needs assessment to quantify AISU in individuals with cancer seeking care in the radiation oncology department of a large, academic medical center.

Methods: Medical records were reviewed for all patients seen in the radiation oncology department in a one-week (five-day) period in the fall of 2014 (N = 397). Demographic and prevalence data were analyzed.

Findings: The prevalence rates of AISU in this sample were slightly lower than estimates for the general population and inconsistency was noted in the documentation of relevant information. Despite the limitations, data analyses suggested that a significant percentage of patients receiving radiation therapy for cancer diagnoses exhibited substance use patterns that placed them at increased risk for negative short- and long-term outcomes. The findings support the need for systematic substance use screening, assessment, and risk-based interventions as an essential component of comprehensive cancer care.

View Article @ cjon.ons.org

ONS Voice Articles

ONS's member magazine articles.

View All Voice Articles

Related Topics